New Take On Growth Factor Signaling In Tamoxifen Resistance
Tuesday, June 30, 2009 - 09:21
in Health & Medicine
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.